BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18684225)

  • 1. Nitric oxide-releasing compounds inhibit the production of interleukin-2, -4 and -10 in activated human lymphocytes.
    Korhonen R; Kosonen O; Hämäläinen M; Moilanen E
    Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):322-8. PubMed ID: 18684225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP.
    Niedbala W; Wei XQ; Campbell C; Thomson D; Komai-Koma M; Liew FY
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16186-91. PubMed ID: 12451176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nitric oxide and TH1/TH2 cytokine supplementation over ectopic endometrial tissue growth in a murine model of endometriosis.
    Mier-Cabrera J; González-Gallardo S; Hernández-Guerrero C
    Reprod Sci; 2013 Nov; 20(11):1332-8. PubMed ID: 23599372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of suplatast tosilate (IPD-1151T) on innate immunity and antigen-presenting cells.
    Hsu LW; Yang CH; Goto S; Nakano T; Lai CY; Lin YC; Kao YH; Chen SH; Cheng YF; Jawan B; Chiu KW; Tsao FK; Chen CL
    Transpl Immunol; 2007 Nov; 18(2):108-14. PubMed ID: 18005853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of electroacupuncture on TH1/TH2 cytokine mRNA expression and mitogen-activated protein kinase signaling pathways in the splenic T cells of traumatized rats.
    Wang K; Wu H; Wang G; Li M; Zhang Z; Gu G
    Anesth Analg; 2009 Nov; 109(5):1666-73. PubMed ID: 19843806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide contributes to the development of a post-injury Th2 T-cell phenotype and immune dysfunction.
    Daniel T; Alexander M; Hubbard WJ; Chaudry IH; Choudhry MA; Schwacha MG
    J Cell Physiol; 2006 Aug; 208(2):418-27. PubMed ID: 16642464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential protective properties of a stable, slow-releasing nitric oxide donor, GEA 3175, in the lung.
    Laursen BE; Stankevicius E; Pilegaard H; Mulvany M; Simonsen U
    Cardiovasc Drug Rev; 2006; 24(3-4):247-60. PubMed ID: 17214601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stemucronatoside L, a pregnane glycoside from the roots of Stephanotis mucronata, inhibits Th1/Th2 immune responses in vitro.
    Chen FY; Ye YP; Sun HX; Li XY; Shi H
    Chem Biodivers; 2009 Jun; 6(6):916-23. PubMed ID: 19551733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells.
    Bauer H; Jung T; Tsikas D; Stichtenoth DO; Frölich JC; Neumann C
    Immunology; 1997 Feb; 90(2):205-11. PubMed ID: 9135548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
    Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory cytokines suppress epithelial nitric oxide production in inflammatory bowel disease by acting on mononuclear cells.
    Linehan JD; Kolios G; Valatas V; Robertson DA; Westwick J
    Free Radic Biol Med; 2005 Dec; 39(12):1560-9. PubMed ID: 16298681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of GEA 3175 on human platelets; comparison with S-nitroso-N-acetyl-D,L-penicillamine.
    Asplund Persson AK; Palmér L; Gunnarsson P; Grenegård M
    Eur J Pharmacol; 2004 Aug; 496(1-3):1-9. PubMed ID: 15288569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 5-fluorouracil on human mitogen-activated peripheral blood lymphocytes from healthy individuals.
    Eisenthal A; Eytan K; Brazowski E; Katz BZ; Shirazi I; Skornick Y
    Anticancer Res; 2008; 28(6A):3785-91. PubMed ID: 19189665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of nitric oxide on the production of cyclic AMP by a human osteoblast (HOS) cell line stimulated with hydroxyapatite.
    Sosroseno W; Sugiatno E; Samsudin AR; Ibrahim MF
    Biomed Pharmacother; 2008 Jun; 62(5):328-32. PubMed ID: 17988826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous nitric oxide modulates cytokine production in human leukocytes.
    Kallmann BA; Malzkorn R; Kolb H
    Life Sci; 1999; 65(17):1787-94. PubMed ID: 10576558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide regulation of human peripheral blood mononuclear cells: critical time dependence and selectivity for cytokine versus chemokine expression.
    Macphail SE; Gibney CA; Brooks BM; Booth CG; Flanagan BF; Coleman JW
    J Immunol; 2003 Nov; 171(9):4809-15. PubMed ID: 14568959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of supplementation with garlic oil on activity of Th1 and Th2 lymphocytes from rats.
    Liu CT; Su HM; Lii CK; Sheen LY
    Planta Med; 2009 Feb; 75(3):205-10. PubMed ID: 19137499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of nitric oxide on the production of prostaglandin E2 by hydroxyapatite-stimulated a human osteoblast (HOS) cell line.
    Sugiatno E; Samsudin AR; Ibrahim MF; Sosroseno W
    Biomed Pharmacother; 2006 May; 60(4):147-51. PubMed ID: 16581222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human lymphocyte proliferation by nitric oxide-releasing oxatriazole derivatives.
    Kosonen O; Kankaanranta H; Vuorinen P; Moilanen E
    Eur J Pharmacol; 1997 Oct; 337(1):55-61. PubMed ID: 9389381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes.
    Park E; Jia J; Quinn MR; Schuller-Levis G
    Clin Immunol; 2002 Feb; 102(2):179-84. PubMed ID: 11846460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.